Literature DB >> 15465323

Protein glycosylation lessons from Caenorhabditis elegans.

Harry Schachter1.   

Abstract

From observations on human diseases and mutant mice, it has become clear that glycosylation plays a major role in metazoan development. Caenorhabditis elegans provides powerful tools to study this problem that are not available in men or mice. The worm has many genes homologous to mammalian genes involved in glycosylation. Glycobiologists have, in recent years, cloned and expressed some of these genes and studied the effects of mutations on worm development. Recent studies have focused on N-glycosylation, lumenal nucleoside diphosphatases, the resistance of C. elegans to a bacterial toxin and infections, fucosylation and proteoglycans. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465323     DOI: 10.1016/j.sbi.2004.09.005

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  15 in total

1.  Mass spectrometric comparison of N-glycan profiles from Caenorhabditis elegans mutant embryos.

Authors:  Hildegard Geyer; Martin Schmidt; Matthias Müller; Ralf Schnabel; Rudolf Geyer
Journal:  Glycoconj J       Date:  2012-03-10       Impact factor: 2.916

2.  The conserved oligomeric Golgi complex is required for fucosylation of N-glycans in Caenorhabditis elegans.

Authors:  Weston B Struwe; Vernon N Reinhold
Journal:  Glycobiology       Date:  2012-02-28       Impact factor: 4.313

Review 3.  Life is sweet! A novel role for N-glycans in Drosophila lifespan.

Authors:  Harry Schachter; Gabrielle Boulianne
Journal:  Fly (Austin)       Date:  2011-01-01       Impact factor: 2.160

4.  A comprehensive Caenorhabditis elegans N-glycan shotgun array.

Authors:  Ewa Jankowska; Lisa M Parsons; Xuezheng Song; Dave F Smith; Richard D Cummings; John F Cipollo
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

5.  Developmental defects in a Caenorhabditis elegans model for type III galactosemia.

Authors:  Ana M Brokate-Llanos; José M Monje; Piedad Del Socorro Murdoch; Manuel J Muñoz
Journal:  Genetics       Date:  2014-10-08       Impact factor: 4.562

6.  RNAi screening of human glycogene orthologs in the nematode Caenorhabditis elegans and the construction of the C. elegans glycogene database.

Authors:  Sayaka Akiyoshi; Kazuko H Nomura; Katsufumi Dejima; Daisuke Murata; Ayako Matsuda; Nanako Kanaki; Tetsuro Takaki; Hiroyuki Mihara; Takayuki Nagaishi; Shuhei Furukawa; Keiko-Gengyo Ando; Sawako Yoshina; Shohei Mitani; Akira Togayachi; Yoshinori Suzuki; Toshihide Shikanai; Hisashi Narimatsu; Kazuya Nomura
Journal:  Glycobiology       Date:  2014-08-04       Impact factor: 4.313

7.  APY-1, a novel Caenorhabditis elegans apyrase involved in unfolded protein response signalling and stress responses.

Authors:  D Uccelletti; A Pascoli; F Farina; A Alberti; P Mancini; C B Hirschberg; C Palleschi
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

Review 8.  Characterization of C. elegans Chondroitin Proteoglycans and Their Large Functional and Structural Heterogeneity; Evolutionary Aspects on Structural Differences Between Humans and the Nematode.

Authors:  Fredrik Noborn; Göran Larson
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Glycosylation diseases: quo vadis?

Authors:  Harry Schachter; Hudson H Freeze
Journal:  Biochim Biophys Acta       Date:  2008-11-13

10.  Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.

Authors:  Weston B Struwe; Bethany L Hughes; David W Osborn; Erica D Boudreau; Kristin M D Shaw; Charles E Warren
Journal:  Glycobiology       Date:  2009-09-03       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.